Injection drug use is an important driver of HIV epidemics in different regions of the world including India, which is home to 168,000–1.1 million people who inject drugs with a high prevalence of HIV and…
Read more »
HIV-associated sensory peripheral neuropathy (HIV-SN) is a length-dependent distal symmetrical polyneuropathy that occurs in individuals with treated and untreated HIV infection…
Read more »
Co-infection of Human immunodeficiency virus (HIV) and tuberculosis (TB) is a major public health concern. Recent estimates indicated about 9 million new cases of TB annually worldwide, of which 1.1 million are people living with HIV…
Read more »
Both the 2010 and 2013 WHO Guidelines on the use of antiretroviral drugs for treating and preventing HIV infection have emphasized a) the phasing out of stavudine (d4T) and replacement with tenofovir…
Read more »
HCV co-infection is recognized as a major cause of morbidity and mortality among HIV-1 infected patients. HIV-1 co-infection is associated with increased HCV load and accelerated rates of liver disease progression…
Read more »
Globally, it is estimated that 35.3 million [32.2 million–38.8 million] people were living with HIV (PLHIV) by the year 2012. At the same time while about 1.5 million people die from HIV/AIDS-related causes, about 2.1 million new cases of HIV were detected…
Read more »
indicates a Peer-Reviewed Article
Sub-Therapeutic Nevirapine Concentration During Antiretroviral Treatment Initiation Among Children Living with HIV: Implications for Therapeutic Drug Monitoring
Nevirapine was the first non-nucleoside reverse transcriptase inhibitor approved by the FDA for pediatric use since 1998. Although nevirapine has a low genetic barrier to…
Read more »